PURPOSE

This institute is designed to strengthen the capacity of the HIV care and prevention workforce to optimally plan, implement, and sustain high-impact HIV prevention (HIP) and HIV care interventions and strategies under the new DC Department of Health’s business process within CBOs, community partners and healthcare organizations to reduce HIV infections and HIV-related morbidity, mortality, and health disparities across the Greater Washington regional area.

STRATEGY

Effi Barry Training Institute provides trainings and technical assistance to support current and prospective HAHSTA grantees and community-based organizations in the Fee-for-Service business process; basic HIV service competencies; advanced skills in health care systems, data and health informatics; high-impact prevention programs, including biomedical; and emerging evidence-based or informed approaches through a series of group-level trainings, boot camps, community forums, and individual consultation.

OUTCOMES

The institute is expected to demonstrate measurable progress toward addressing the short-term outcomes listed below. These include:

1. Increased accessibility, availability and utilization of culturally and linguistically appropriate capacity building assistance including state-of-the-science information, training, and technical assistance including consultation, services, and facilitation of peer-to-peer mentoring for all service areas and supporting activities;

2. Improved capacity of the community providers and workforce to implement the new DOH business model, innovative approaches to HIP, HIV care/treatment, and supporting activities, including increases in their knowledge, skills, self-efficacy, and intended use of capacity; and

3. Improved provision of quality service approaches that are available to consumers within the Washington DC regional area.

HISTORY

Since 2007, the Council of the District of Columbia and DOH HAHSTA have invested over $4,950,000 in District-based organizations through the Effi Barry HIV/AIDS Program/East of the River Project. To date the Effi Barry HIV Program has provided capacity building grants and group/individual-level capacity building assistance to over 100 organizations based in the District of Columbia. This effort has directly benefitted their ability to develop new innovative approach and/or expand a range of prevention-focused programs that promote testing, maintain treatment, PrEP, and eliminate stigma. 

Visit EffiBarryInstitute.org for more information.


Healthcare providers have continued to experience worsening mental health symptoms, which can be exacerbated during the holiday season. This offering reimagines mental health as an essential component of whole-body wellness, identifies coping strategies to re-set, refocus and refresh, and provides an understanding of people-centered resources.

Faculty: Ebony Johnson, A Drop of Prevention

Learning Objectives:

1. Examine the importance of mental health in expanding providers' overall health and quality of life

2. Explore communication tools, self-care strategies, and coping techniques to counter holiday stressors

3. Identify community and workplace resources to reduce stress, improve mental health, and provide healthy options for self-care

NOTE: This module does NOT award credits.


This presentation covers the myths and facts about HIV and AIDS in Washington, DC and serves as an introduction to those new to the topic.

Please review the content below at your own pace.

Release Date: December 7, 2022 

Expiration Date: December 7, 2023

Target Audience

This activity is intended for physicians, pharmacists, registered nurses, PAs, psychologists, social workers and other healthcare providers engaged in the care of patients with HIV.

Educational Objectives

After completing this activity, the participant should be better able to:

  • Define HIV and AIDS
    • Describe how HIV affects the body
      • Identify the different types of antiretroviral drugs used to treat HIV
        • Describe the prevalence of HIV in the U.S. and in DC specifically among specific subpopulations
          • List the routes by which HIV can and cannot be transmitted
          • Define harm reduction techniques to reduce the risk of HIV transmission
          • List the three types of HIV tests and how they are used

          Faculty

          Corey Howell, CHES®

          Disclosure of Conflicts of Interest

          Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

          The faculty have nothing to disclose.

          The PIM planners and others have nothing to disclose. The HealthHIV planners and others have nothing to disclose.

          Joint Accreditation Statement

          Jointly Accredited Provider: Interprofessional Continuing EducationIn support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and HealthHIV. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

          Physician Continuing Medical Education

          The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

          Continuing Nursing Education

          The maximum number of hours awarded for this Continuing Nursing Education activity is 1.5 contact hours.

          Continuing Pharmacy Education

          Postgraduate Institute for Medicine designates this continuing education activity for 1.5 contact hour(s) (0.15 CEUs) of the Accreditation Council for Pharmacy Education.

          Continuing Physician Assistant Education

          AAPA Category 1 CMEPostgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.5 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

          Continuing Social Work Education

          ACE: approved continuing educationAs a Jointly Accredited Organization, Postgraduate Institute for Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Postgraduate Institute for Medicine maintains responsibility for this course. Social workers completing this course receive 1.5 Clinical continuing education credits.

          Disclosure of Unlabeled Use

          This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

          Disclaimer

          Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

          The Fair Housing Act prohibits discrimination in the sale, rental, and financing of dwellings and in other housing-related activities based on disability, among other protected classes. Generally, the Fair Housing Act applies to a broad range of persons and entities, including public housing agencies, property owners, landlords, housing managers, real estate agents, brokerage service agencies, and banks. This webinar will discuss Fair Housing Laws and Regulations as they apply to people living with disabilities and describe reasonable accommodations and modifications.  This training will also identify resources available in the Washington D.C. area for people living with disabilities who are experiencing housing discrimination.

          Faculty: Maria D. Moreno PMP

          Learning Objectives

          1. Describe the history and the different laws that protect the fair housing rights of individuals and what classes are protected under the acts.

          2. Explain the different laws that protect the rights of individuals with disabilities, particularly persons living with HIV/AIDS

          3. Describe the overall process of filing a complaint with a local fair housing agency

          4. Identify fair housing resources and other housing programs that the United States Department of Housing and Urban Development (HUD) offers to individuals with HIV/AIDS

          Motivational Interviewing

          Jointly provided by Postgraduate Institute for Medicine and HealthHIV

          Release Date: September 1, 2022 

          Expiration Date: August 31, 2023

          Target Audience

          This activity is intended for physicians, pharmacists, registered nurses, PAs, psychologists, social workers and other healthcare providers engaged in the care of patients with HIV.

          Educational Objectives

          After completing this activity, the participant should be better able to:

          • Explain the importance of engaging in HIV care
            • Describe tangible forms of support they could provide to a friend or family member living with HIV
              • Describe intangible forms of support they could provide to a friend or family member living with HIV

              Faculty

              Heather Alt, BSN, RN, ACRN, CPH

              Disclosure of Conflicts of Interest

              Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

              The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:

              Employment with Whitman Walker Health.

              The PIM planners and others have nothing to disclose. The HealthHIV planners and others have nothing to disclose.

              Joint Accreditation Statement

              Jointly Accredited Provider: Interprofessional Continuing EducationIn support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and HealthHIV. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

              Physician Continuing Medical Education

              The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

              Continuing Nursing Education

              The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours.

              Continuing Pharmacy Education

              Postgraduate Institute for Medicine designates this continuing education activity for 1.0 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education.

              Continuing Physician Assistant Education

              AAPA Category 1 CMEPostgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

              Continuing Social Work Education

              ACE: approved continuing educationAs a Jointly Accredited Organization, Postgraduate Institute for Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Postgraduate Institute for Medicine maintains responsibility for this course. Social workers completing this course receive 1.0 Cultural continuing education credits.

              Disclosure of Unlabeled Use

              This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

              Disclaimer

              Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

              This session provides participants with an overview of HIV criminalization laws and data, along with strategies for combating HIV stigma and advocating for decriminalization.

              Faculty: Kamaria Laffrey, co-managing director for HIV policy reform with The SERO Project and spokesperson for the treatment adherence and self-care campaign Positively Fearless

              Learning Objectives:

              At the conclusion of this session, you will be able to:

              • Define HIV criminalization and identify the data that is most alarming.
              • Explain five reasons why criminalization is a problem.
              • Describe the nuances of strategy vs. implementation in legislative success.

              NOTE: This session does NOT offer continuing education credits.


              This session provides participants with an overview on primary PrEP care and the challenges providers can face with access, adherence, and retention in Black, Indigenous, and people of color (BIPOC) communities.

              Faculty: Dr. Tyris Ford, DNP, NP-C, FNP-BC, AAHIVS

              Learning Objectives:

              • Explain the importance of increasing PrEP utilization among BIPOC Communities. 
              • Summarize  PrEP formulations and guidelines. 
              • Describe patient and provider concerns regarding PrEP use. 
              • Identify barriers and opportunities to engage and retain BIPOC communities in PrEP uptake.

              NOTE: This session does NOT offer continuing education credits.


              Social Support: Showing Up for Your Person

              Jointly provided by Postgraduate Institute for Medicine and HealthHIV

              Release Date: April 14, 2022 

              Expiration Date: April 15, 2023

              Target Audience

              This activity is intended for physicians, pharmacists, registered nurses, PAs, psychologists, social workers and other healthcare providers engaged in the care of patients with HIV.

              Educational Objectives

              After completing this activity, the participant should be better able to:

              • Explain the importance of engaging in HIV care
                • Describe tangible forms of support they could provide to a friend or family member living with HIV
                  • Describe intangible forms of support they could provide to a friend or family member living with HIV

                  Faculty

                  Heather Alt, BSN, RN, ACRN, CPH

                  Disclosure of Conflicts of Interest

                  Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

                  The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:

                  Employment with Whitman Walker Health.

                  The PIM planners and others have nothing to disclose. The HealthHIV planners and others have nothing to disclose.

                  Joint Accreditation Statement

                  Jointly Accredited Provider: Interprofessional Continuing EducationIn support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and HealthHIV. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

                  Physician Continuing Medical Education

                  The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

                  Continuing Nursing Education

                  The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours.

                  Continuing Pharmacy Education

                  Postgraduate Institute for Medicine designates this continuing education activity for 1.0 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education.

                  Continuing Physician Assistant Education

                  AAPA Category 1 CMEPostgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

                  Continuing Social Work Education

                  ACE: approved continuing educationAs a Jointly Accredited Organization, Postgraduate Institute for Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Postgraduate Institute for Medicine maintains responsibility for this course. Social workers completing this course receive 1.0 Cultural continuing education credits.

                  Disclosure of Unlabeled Use

                  This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

                  Disclaimer

                  Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.